P A Patriarca

Author PubWeight™ 60.87‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Efficacy of influenza vaccine in nursing homes. Reduction in illness and complications during an influenza A (H3N2) epidemic. JAMA 1985 3.85
2 Morbidity and mortality associated with the July 1980 heat wave in St Louis and Kansas City, Mo. JAMA 1982 3.69
3 Outbreak of paralytic poliomyelitis in Oman: evidence for widespread transmission among fully vaccinated children. Lancet 1991 2.64
4 Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine. Lancet 1993 2.24
5 Seroprevalence of antibody against poliovirus in inner-city preschool children. Implications for vaccination policy in the United States. JAMA 1996 1.93
6 Risk factors for outbreaks of influenza in nursing homes. A case-control study. Am J Epidemiol 1986 1.93
7 Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization. Ann Intern Med 1994 1.79
8 The case for global eradication of poliomyelitis. Bull World Health Organ 1987 1.72
9 Epidemiological features of pertussis in the United States, 1980-1989. Clin Infect Dis 1992 1.55
10 Lack of significant person-to-person spread of swine influenza-like virus following fatal infection in an immunocompromised child. Am J Epidemiol 1984 1.47
11 Safety of prolonged administration of rimantadine hydrochloride in the prophylaxis of influenza A virus infections in nursing homes. Antimicrob Agents Chemother 1984 1.42
12 Evaluation of telephoned computer-generated reminders to improve immunization coverage at inner-city clinics. Public Health Rep 1993 1.40
13 Preparing for pandemic influenza: the need for enhanced surveillance. Emerg Infect Dis 1999 1.32
14 Risk factors for community- and household-acquired pertussis during a large-scale outbreak in central Wisconsin. J Infect Dis 1988 1.31
15 Current poliomyelitis immunization policy in the United States. Pediatr Ann 1990 1.28
16 A randomized controlled trial of influenza vaccine in the elderly. Scientific scrutiny and ethical responsibility. JAMA 1994 1.17
17 Use of influenza vaccine in nursing homes. J Am Geriatr Soc 1985 1.14
18 Principles of measles control. Bull World Health Organ 1991 1.13
19 The roles of vaccination and amantadine prophylaxis in controlling an outbreak of influenza A (H3N2) in a nursing home. Arch Intern Med 1988 1.12
20 Paralytic poliomyelitis in Romania, 1984-1992. Evidence for a high risk of vaccine-associated disease and reintroduction of wild-virus infection. Am J Epidemiol 1994 1.09
21 The effect of diarrhea on oral poliovirus vaccine failure in Brazil. J Infect Dis 1997 1.08
22 Kawasaki syndrome: association with the application of rug shampoo. Lancet 1982 1.06
23 Changing levels of measles antibody titers in women and children in the United States: impact on response to vaccination. Kaiser Permanente Measles Vaccine Trial Team. Pediatrics 1996 1.06
24 A randomized trial of the effectiveness of computer-generated telephone messages in increasing immunization visits among preschool children. Arch Pediatr Adolesc Med 1994 1.04
25 Clinical efficacy of measles vaccine during the 1990 measles epidemic. Pediatr Infect Dis J 1991 1.04
26 Evaluation of house-to-house versus fixed-site oral poliovirus vaccine delivery strategies in a mass immunization campaign in Egypt. Bull World Health Organ 1995 1.03
27 Paralytic poliomyelitis in Oman: association between regional differences in attack rate and variations in antibody responses to oral poliovirus vaccine. Int J Epidemiol 1993 1.01
28 Prevention of secondary transmission of pertussis in households with early use of erythromycin. Am J Dis Child 1992 1.01
29 Humoral and mucosal immunity in infants induced by three sequential inactivated poliovirus vaccine-live attenuated oral poliovirus vaccine immunization schedules. Baltimore Area Polio Vaccine Study Group. J Infect Dis 1997 0.99
30 Acute hemorrhagic conjunctivitis Investigation of a large-scale community outbreak in Dade County, Florida. JAMA 1983 0.98
31 Vaccination levels and missed opportunities for measles vaccination: a record audit in a public pediatric clinic. Pediatrics 1992 0.98
32 Evaluation of the safety, reactogenicity and immunogenicity of FluBlok® trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy adults 50-64 years of age. Vaccine 2011 0.96
33 Hospitalizations for measles, 1970-78. Am J Public Health 1982 0.94
34 Outbreak of paralytic poliomyelitis in a highly immunized population in Jordan. J Infect Dis 1997 0.93
35 Influenza vaccination and warfarin or theophylline toxicity in nursing-home residents. N Engl J Med 1983 0.92
36 Clinical findings and results of treatment in an outbreak of acute hemorrhagic conjunctivitis in southern Florida. Am J Ophthalmol 1983 0.87
37 Pneumococcal vaccination practices among private physicians. Public Health Rep 1982 0.85
38 Comparative immunogenicity of recombinant influenza hemagglutinin (rHA) and trivalent inactivated vaccine (TIV) among persons > or =65 years old. Vaccine 2009 0.85
39 Syncope after immunization. Arch Pediatr Adolesc Med 1997 0.83
40 Ventriculoperitoneal shunt-associated infection due to Haemophilus influenzae. Pediatrics 1980 0.82
41 Virus-specific, early appearing neutralizing activity and interferon in tears of patients with acute hemorrhagic conjunctivitis. Curr Eye Res 1985 0.82
42 Amantadine prophylaxis during an institutional outbreak of type A (H1N1) influenza. Arch Intern Med 1986 0.82
43 Safety and immunogenicity of a 45-microgram supplemental dose of inactivated split-virus influenza B vaccine in the elderly. J Infect Dis 1986 0.81
44 New options for prevention and control of influenza. JAMA 1999 0.80
45 Increased immunogenicity of oral poliovirus vaccine administered in mass vaccination campaigns compared with the routine vaccination program in Jordan. J Infect Dis 1997 0.79
46 Attributable risk of DTP (diphtheria and tetanus toxoids and pertussis vaccine) injection in provoking paralytic poliomyelitis during a large outbreak in Oman. J Infect Dis 1992 0.79
47 Report of a US public health service workshop on hypotonic-hyporesponsive episode (HHE) after pertussis immunization. Pediatrics 1998 0.76
48 Oral poliomyelitis vaccines. Lancet 1996 0.75
49 Influenza vaccine for healthy adults? N Engl J Med 1995 0.75
50 Reye syndrome in connective tissue disease. J Pediatr 1986 0.75
51 Policies and outcomes for control of influenza among the elderly in the USA. Vaccine 1985 0.75
52 Oral rehydration solution as adjuvant for oral vaccination. Lancet 1995 0.75
53 Current epidemiology of pertussis in the United States. Tokai J Exp Clin Med 1988 0.75
54 Advances in antiviral chemotherapy: amantadine and influenza. Med J Aust 1980 0.75
55 Aneurysms following Kawasaki disease. J Pediatr 1982 0.75
56 Poliomyelitis in the United States: a historical perspective and current vaccination policy. J Am Coll Health 1990 0.75
57 Efficacy of acellular pertussis vaccine. J Pediatr 1986 0.75
58 Viral respiratory illnesses. Med Clin North Am 1983 0.75
59 An outbreak of acute hemorrhagic conjunctivitis in central Minnesota. Am J Ophthalmol 1983 0.75
60 Class-specific antibody responses in school children vaccinated with an A/Brazil/11/78 (H1N1)-like recombinant influenza virus prepared from the A/Leningrad/134/57 paediatric cold-adapted donor strain. Vaccine 1988 0.75